306 related articles for article (PubMed ID: 27138569)
1. Checkpoint inhibitors and gastrointestinal immune-related adverse events.
Pernot S; Ramtohul T; Taieb J
Curr Opin Oncol; 2016 Jul; 28(4):264-8. PubMed ID: 27138569
[TBL] [Abstract][Full Text] [Related]
2. Gastrointestinal and Hepatic Complications of Immune Checkpoint Inhibitors.
Cramer P; Bresalier RS
Curr Gastroenterol Rep; 2017 Jan; 19(1):3. PubMed ID: 28124291
[TBL] [Abstract][Full Text] [Related]
3. Immune Checkpoint Inhibitor-Associated Colitis and Hepatitis.
Reddy HG; Schneider BJ; Tai AW
Clin Transl Gastroenterol; 2018 Sep; 9(9):180. PubMed ID: 30228268
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory bowel disease and cancer response due to anti-CTLA-4: is it in the flora?
Carbonnel F; Soularue E; Coutzac C; Chaput N; Mateus C; Lepage P; Robert C
Semin Immunopathol; 2017 Apr; 39(3):327-331. PubMed ID: 28093620
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis, clinical manifestations and management of immune checkpoint inhibitors toxicity.
Inno A; Metro G; Bironzo P; Grimaldi AM; Grego E; Di Nunno V; Picasso V; Massari F; Gori S
Tumori; 2017 Sep; 103(5):405-421. PubMed ID: 28497847
[TBL] [Abstract][Full Text] [Related]
6. Checkpoint Inhibitor-Induced Colitis.
Bellaguarda E; Hanauer S
Am J Gastroenterol; 2020 Feb; 115(2):202-210. PubMed ID: 31922959
[TBL] [Abstract][Full Text] [Related]
7. Systematic review: colitis associated with anti-CTLA-4 therapy.
Gupta A; De Felice KM; Loftus EV; Khanna S
Aliment Pharmacol Ther; 2015 Aug; 42(4):406-17. PubMed ID: 26079306
[TBL] [Abstract][Full Text] [Related]
8. Managing immune checkpoint-blocking antibody side effects.
Postow MA
Am Soc Clin Oncol Educ Book; 2015; ():76-83. PubMed ID: 25993145
[TBL] [Abstract][Full Text] [Related]
9. Management of toxicities of immune checkpoint inhibitors.
Spain L; Diem S; Larkin J
Cancer Treat Rev; 2016 Mar; 44():51-60. PubMed ID: 26874776
[TBL] [Abstract][Full Text] [Related]
10. Recent developments and future challenges in immune checkpoint inhibitory cancer treatment.
Koster BD; de Gruijl TD; van den Eertwegh AJ
Curr Opin Oncol; 2015 Nov; 27(6):482-8. PubMed ID: 26352539
[TBL] [Abstract][Full Text] [Related]
11. Endocrine side effects induced by immune checkpoint inhibitors.
Corsello SM; Barnabei A; Marchetti P; De Vecchis L; Salvatori R; Torino F
J Clin Endocrinol Metab; 2013 Apr; 98(4):1361-75. PubMed ID: 23471977
[TBL] [Abstract][Full Text] [Related]
12. Ocular and orbital side-effects of checkpoint inhibitors: a review article.
Antoun J; Titah C; Cochereau I
Curr Opin Oncol; 2016 Jul; 28(4):288-94. PubMed ID: 27136135
[TBL] [Abstract][Full Text] [Related]
13. Immune Checkpoint Inhibitor-Induced Colitis: Diagnosis and Management.
Prieux-Klotz C; Dior M; Damotte D; Dreanic J; Brieau B; Brezault C; Abitbol V; Chaussade S; Coriat R
Target Oncol; 2017 Jun; 12(3):301-308. PubMed ID: 28540478
[TBL] [Abstract][Full Text] [Related]
14. Immune-related adverse events with immune checkpoint blockade: a comprehensive review.
Michot JM; Bigenwald C; Champiat S; Collins M; Carbonnel F; Postel-Vinay S; Berdelou A; Varga A; Bahleda R; Hollebecque A; Massard C; Fuerea A; Ribrag V; Gazzah A; Armand JP; Amellal N; Angevin E; Noel N; Boutros C; Mateus C; Robert C; Soria JC; Marabelle A; Lambotte O
Eur J Cancer; 2016 Feb; 54():139-148. PubMed ID: 26765102
[TBL] [Abstract][Full Text] [Related]
15. Checkpoint inhibitor colitis: a new model of inflammatory bowel disease?
Siakavellas SI; Bamias G
Curr Opin Gastroenterol; 2018 Nov; 34(6):377-383. PubMed ID: 30157044
[TBL] [Abstract][Full Text] [Related]
16. Immune-related adverse events in the gastrointestinal tract: diagnostic utility of upper gastrointestinal biopsies.
Zhang ML; Neyaz A; Patil D; Chen J; Dougan M; Deshpande V
Histopathology; 2020 Jan; 76(2):233-243. PubMed ID: 31361907
[TBL] [Abstract][Full Text] [Related]
17. Gastrointestinal toxicity of immune checkpoint inhibitors: from mechanisms to management.
Samaan MA; Pavlidis P; Papa S; Powell N; Irving PM
Nat Rev Gastroenterol Hepatol; 2018 Apr; 15(4):222-234. PubMed ID: 29512649
[TBL] [Abstract][Full Text] [Related]
18. [Immune-related adverse events by immune checkpoint inhibitors].
Kadono T
Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(2):83-89. PubMed ID: 28603205
[TBL] [Abstract][Full Text] [Related]
19. Immune modulation in cancer with antibodies.
Page DB; Postow MA; Callahan MK; Allison JP; Wolchok JD
Annu Rev Med; 2014; 65():185-202. PubMed ID: 24188664
[TBL] [Abstract][Full Text] [Related]
20. Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis.
Wang Y; Wiesnoski DH; Helmink BA; Gopalakrishnan V; Choi K; DuPont HL; Jiang ZD; Abu-Sbeih H; Sanchez CA; Chang CC; Parra ER; Francisco-Cruz A; Raju GS; Stroehlein JR; Campbell MT; Gao J; Subudhi SK; Maru DM; Blando JM; Lazar AJ; Allison JP; Sharma P; Tetzlaff MT; Wargo JA; Jenq RR
Nat Med; 2018 Dec; 24(12):1804-1808. PubMed ID: 30420754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]